Moderna may be facing regulatory uncertainty in the US for its vaccine pipeline, but at least its clinical data is hitting the right notes.

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

The Centers for Disease Control and Prevention (CDC) yesterday declared its investigation into a multistate Salmonella ...

The new cases are part of a national surge fueled by multiple factors, including a large outbreak in West Texas, illnesses ...